USA - engelska - NLM (National Library of Medicine)

jubilant hollisterstier llc - sorghum halepense pollen (unii: 577va5b4hp) (sorghum halepense pollen - unii:577va5b4hp) - sorghum halepense pollen 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

USA - engelska - NLM (National Library of Medicine)

jubilant hollisterstier llc - bromus inermis pollen (unii: 766qt72bk6) (bromus inermis pollen - unii:766qt72bk6) - bromus inermis pollen 0.05 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

allergy therapeutics (uk) ltd - oak (common, quercus species) pollen allergen extract; salix species pollen allergen extract; poplar (populus species) pollen allergen extract; plane (platanus species) pollen allergen extract; hazel (corylus species) pollen allergen extract; ulmus species pollen allergen extract; birch (betula species) pollen allergen extract; beech (fagus species) pollen allergen extract; ash (fraxinus species) pollen allergen extract; alder (alnus species) pollen allergen extract - solution for skin-prick test

Australien - engelska - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - plantago lanceolata; triticum aestivum; olea europaea; european house dust mite extract; american house dust mite extract; dermatophagoides pteronyssinus body extract; dermatophagoides farinae body extract; lolium perenne; phleum pratense; dactylis glomerata; anthoxanthum odoratum; poa pratensis; cynodon dactylon; mannitol; arrhenatherum elatius; holcus lanatus; avena fatua; bromus inermis; agrostis tenuis; festuca elatior; holcus latanus; cynodon dactylon pollen extract; dermatophagoides farinae body extra -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - dactylis glomerata, quantity: 2 ir/ml; anthoxanthum odoratum, quantity: 2 ir/ml; phleum pratense, quantity: 2 ir/ml; lolium perenne, quantity: 2 ir/ml; poa pratensis, quantity: 2 ir/ml - injection, suspension - excipient ingredients: sodium chloride; phenol; mannitol; aluminium hydroxide hydrate; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - lolium perenne, quantity: 2 ir/ml; phleum pratense, quantity: 2 ir/ml; poa pratensis, quantity: 2 ir/ml; anthoxanthum odoratum, quantity: 2 ir/ml; dactylis glomerata, quantity: 2 ir/ml - injection, suspension - excipient ingredients: phenol; aluminium hydroxide hydrate; water for injections; sodium chloride; mannitol - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - olea europaea, quantity: 10 ir/ml - injection, suspension - excipient ingredients: sodium chloride; phenol; mannitol; aluminium hydroxide hydrate; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - olea europaea, quantity: 10 ir/ml - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; sodium chloride; mannitol; phenol; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - plantago lanceolata -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - plantago lanceolata -